abstract |
The present invention relates to a process for the preparation of a solid, orally administrable pharmaceutical composition containing 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) -phenyl] -1,3-oxazolidin 5-yl} -methyl) -2-thiophenecarboxamide in hydrophilized form and their use for the prophylaxis and / or treatment of diseases. |